Association of seropositivity for antibody to Chlamydia-specific lipopolysaccharide and coronary artery disease in Japanese men

Japanese Circulation Journal

Volumn 65, Issue 3, 2001, Pages 182-187

  Shimada, K ^a   Daida, H ^a   Mokuno, H ^a   Watanabe, Y ^a   Sawano, M ^a   Iwama, Y ^a   Seki, E ^a   Kurata, T ^a   Sato, H ^a   Ohashi, S ^a   Suzuki, H ^a   Miyauchi, K ^a   Takaya, J ^a   Sakurai, H ^a   Yamaguchi, H ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Chlamydia lipopolysaccharide; Chlamydia pneumoniae; Coronary artery disease; Myocardial infarction

Indexed keywords

BACTERIUM ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; JAPAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; RISK ASSESSMENT; SERODIAGNOSIS; SEROLOGY;

AGED; ANTIBODIES, BACTERIAL; CHLAMYDIA; CHLAMYDIA INFECTIONS; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; JAPAN; LIPOPOLYSACCHARIDES; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; MYOCARDIAL INFARCTION; SEROEPIDEMIOLOGIC STUDIES;

EID: 0035108992     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.65.182     Document Type: Article

References (54)

1. Atherosclerosis: An inflammatory disease
2. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease
3. Novel inflammatory markers of coronary risk
4. Five-year intra-individual variability in C-reactive protein levels in a Japanese population-based study: The Jichi Medical School Cohort Study at Yamato, 1993-1998
5. Viruses are etiology of atherosclerosis
6. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis
7. Relation of Helicobacter pylori infection and coronary heart disease
8. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
9. Chlamydia pneumoniae stain TWAR antibody and angiographically demonstrated coronary artery disease
10. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease
11. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study
12. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease
13. Chlamydia pneumoniae and acute arterial thrombotic disease
14. Chlamydia pneumoniae antibody response in patients with acute myocardial infarction and their follow-up
15. Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease
16. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not
17. Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly prospective heart disease study
18. Chlamydia pneumoniae infection and atherosclerotic coronary disease
19. Serological evidence of Chlamydia pneumoniae lipopolysaccharide antibodies in atherosclerosis of various vascular regions
20. Infections, inflammation, and the risk of coronary heart disease
21. Clinical significance of anti-Chlamydia pneumoniae IgG-antibody titer elevation in coronary artery disease
22. An association of antibody against Chlamydia pneumoniae and coronary heart disease observed in Japan
23. Association of chronic infection of Chlamydia pneumoniae and coronary heart disease in the Japanese
24. Association between Chlamydia infection and coronary artery disease in Japanese population
25. Association between chlamydial infection and coronary artery disease
26. High prevalence of seropositivity for Chlamydia-specific lipopolysaccharide in patients with acute coronary syndrome
27. Chlamydia Pneumoniae sp. nov. for Chlamydia sp. strain TWAR
28. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries
29. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues
30. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerosis versus other forms of cardiovascular disease
31. Characterization of murine monoclonal and murine, rabbit, and human polyclonal antibodies against chlamydial lipopolysaccharide
32. Structure, serological specificity, and synthesis of artificial glycoconjugates representing the genus-specific lipopolysaccharide epitope of Chlamydia spp
33. Occurrence of antibodies against chlamydial lipopolysaccharide in human sera as measured by ELISA using an artificial glycoconjugate antigen
34. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae
35. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in human monocyte cell line
36. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-α and matrix metalloproteinase expression
37. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages
38. The pathogenesis of coronary artery disease and the acute coronary syndromes
39. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
40. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-κB and induces tissue factor and PAI-1 expression: A potential link to accelerated atherosclerosis
41. Acute respiratorytract infections and risk of first-time acute myocardial infarction
42. Elevated Chlamydin pneumoniae antibodies, cardiovascular events, and azythromycin in male survivors of myocardial infarction
43. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes: The final report of ROXIS study
44. Chlamydia pneumoniae, strain TWAR and atherosclerosis
45. Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association
46. Structure and function of immunoglobulin A
47. Cell-mediated immunity to Chlamydia Pneumoniae measured as lymphocyte blast transformation in vitro
48. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction
49. Lack of association between prior infection with Chlamydia pneumoniae and acute coronary artery disease
50. Chlamydia pneumoniae antibodies and angiographically demonstrated coronary artery disease in a sample population from Italy
51. Coronary angiplasty induces rise in Chlamydai pneumoniae-specific antibodies
52. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR
53. Structual and antigenic analysis of Chlamydia pneumoniae
54. Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 1: Evaluation of ELISA kit using outer membrane complex